PhRMA's court win over HHS could be a boon for pharma patient assistance programs
As out-of-pocket costs have risen for patients in the US in recent years, pharma manufacturers have offered financial assistance — including to those with commercial insurance — to better shoulder these higher costs.
Catching on to the extent of this financial assistance, commercial health insurers have sought to pocket at least some of that extra money, devising complex schemes known as “accumulator adjustment programs,” that basically carve out this pharma assistance when calculating an insured person’s annual deductible and copayment for a drug.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.